Skip to main content
NCBI home page
Gut logoLink to Gut
. 1987 Feb;28(2):150–155. doi: 10.1136/gut.28.2.150

Optimum dosage of ispaghula husk in patients with irritable bowel syndrome: correlation of symptom relief with whole gut transit time and stool weight.

A Kumar, N Kumar, J C Vij, S K Sarin, B S Anand
PMCID: PMC1432983  PMID: 3030900

Abstract

To determine the optimum dose of ispaghula husk in patients with irritable bowel syndrome (IBS) and to assess the correlation, if any between the relief in patients' symptoms and the whole gut transit time, and the increase in stool weight, a two part study was carried out. In part 1, 14 male patients were given ispaghula husk in increasing doses of 10 g, 20 g, and 30 g a day for a duration of 17 days each (14 days of study period + three days of stool collection). Ten patients completed the trial. The symptom score improved significantly with all the three doses of ispaghula. Both 20 g and 30 g doses of ispaghula were superior to the 10 g dose but there was no significant difference between the 20 g and 30 g doses. There was a significant (p less than 0.001) increase in the daily stool weight with 10 g dose of fibre with further significant increases with the 20 g and 30 g doses. A positive correlation was seen between the improvement in the symptom score and the increase in stool weight with the 10 g dose of ispaghula but not with the 20 g and 30 g doses. Whole gut transit time remained fairly constant throughout the study period and there was no relationship with either the dose of ispaghula, the alteration in stool weight, or the improvement in the patients symptoms. Ten patients completed part 2 of the study in which ispaghula husk was given in the same dose (10 g, 20 g, and 30 g) but in a random order and with a "washout" period of one week between individual doses. Again all the three doses of ispaghula produced a significant improvement in the symptoms; 20 g and 30 g doses were equally effective and both were significantly superior to the 10 g dose. Assessed individually, all the three symptoms improved significantly; improvement in constipation and pain abdomen was more pronounced than diarrhoea. It is concluded that the optimum dose of ispaghula husk in irritable bowel syndrome is 20 g per day. There is some correlation between the increase in stool weight and the improvement in symptom score but the whole gut transit time remains unchanged despite alterations in stool weight and patients' symptoms.

Full text

PDF
150

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cann P. A., Read N. W., Holdsworth C. D. What is the benefit of coarse wheat bran in patients with irritable bowel syndrome? Gut. 1984 Feb;25(2):168–173. doi: 10.1136/gut.25.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Golechha A. C., Chadda V. S., Chadda S., Sharma S. K., Mishra S. N. Role of ispaghula husk in the management of irritable bowel syndrome (a randomized double-blind crossover study). J Assoc Physicians India. 1982 Jun;30(6):353–355. [PubMed] [Google Scholar]
  3. Hillman L. C., Stace N. H., Pomare E. W. Irritable bowel patients and their long-term response to a high fiber diet. Am J Gastroenterol. 1984 Jan;79(1):1–7. [PubMed] [Google Scholar]
  4. Hinton J. M., Lennard-Jones J. E., Young A. C. A ne method for studying gut transit times using radioopaque markers. Gut. 1969 Oct;10(10):842–847. doi: 10.1136/gut.10.10.842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Longstreth G. F., Fox D. D., Youkeles L., Forsythe A. B., Wolochow D. A. Psyllium therapy in the irritable bowel syndrome. A double-blind trial. Ann Intern Med. 1981 Jul;95(1):53–56. doi: 10.7326/0003-4819-95-1-53. [DOI] [PubMed] [Google Scholar]
  6. Manning A. P., Heaton K. W., Harvey R. F. Wheat fibre and irritable bowel syndrome. A controlled trial. Lancet. 1977 Aug 27;2(8035):417–418. doi: 10.1016/s0140-6736(77)90605-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Nigam P., Kapoor K. K., Rastog C. K., Kumar A., Gupta A. K. Different therapeutic regimens in irritable bowel syndrome. J Assoc Physicians India. 1984 Dec;32(12):1041–1044. [PubMed] [Google Scholar]
  8. Rees W. D., Rhodes J. Altered bowel habit and menstruation. Lancet. 1976 Aug 28;2(7983):475–475. doi: 10.1016/s0140-6736(76)92575-7. [DOI] [PubMed] [Google Scholar]
  9. Ritchie J. A., Truelove S. C. Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk. Br Med J. 1979 Feb 10;1(6160):376–378. doi: 10.1136/bmj.1.6160.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Soltoft J., Krag B., Gudmand-Hoyer E., Kristensen E., Wulff H. R. A double-blind trial of the effect of wheat bran on symptoms of irritable bowel syndrome. Lancet. 1976 Feb 7;1(7954):270–272. doi: 10.1016/s0140-6736(76)91402-1. [DOI] [PubMed] [Google Scholar]
  11. Tandon R. K., Prasad N., Gupta M. C., Tandon B. N. Stool weights and transit time in North Indians. J Assoc Physicians India. 1976 Dec;24(12):807–810. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES